GraphWear Technologies Inc.
#notblood
#notblood
GraphWear Technologies Inc. is a Silicon Valley-based healthcare technology company focused on revolutionizing the way chronic diseases are diagnosed and monitored. The company's needle-free continuous glucose monitoring system is a game-changer in diabetes management, offering a non-invasive and continuous approach to monitoring glucose levels without the need for blood or urine samples.
Founded in 2015, GraphWear has garnered significant attention and support from investors. The company recently secured a $20.50M Series B investment on 05 October 2021, with prominent backers including Builders VC, Mayfield, Mission BioCapital, and VSC Ventures.
With its cutting-edge approach to healthcare technology and a strong investor backing, GraphWear is well-positioned to disrupt the healthcare industry and make a meaningful impact on the lives of individuals managing chronic diseases.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series B | $20.50M | 4 |
|
05 Oct 2021 |
| Series A | $4.20M | 2 |
|
17 Apr 2018 |
| Seed Round | Unknown | - | 21 Sep 2017 | |
| Non Equity Assistance | Unknown | 1 |
|
31 Jan 2017 |
| Seed Round | $500.00K | - | 29 Dec 2016 |
No recent news or press coverage available for GraphWear Technologies Inc..
We care about your data, and we'd love to use cookies make your experience better.
